During the past decade, Fukui Prefectural Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukui Prefectural Hospital" #1 sponsor was "Bayer" with 7 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "AveXis, Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Daiichi Sankyo Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukui Prefectural Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fukui Prefectural Hospital" are "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Acute Myocardial Infarction" (1 trials), "Atrial Fibrillation" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Fukui Prefectural Hospital" in a lesser frequency.

Most popular intervention types in "Fukui Prefectural Hospital" are "Drug" (11 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukui Prefectural Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Fukui Prefectural Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Fukui Prefectural Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukui Prefectural Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".